Identification of intermediate-risk prostate cancer patients treated with radical radiotherapy suitable for neoadjuvant hormone studies
- 1 January 1996
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 38 (1) , 7-12
- https://doi.org/10.1016/0167-8140(95)01645-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Radical radiotherapy for localized adenocarcinoma of the prostate. A report of 191 casesBritish Journal of Urology, 1995
- 5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate CancerJournal of Urology, 1994
- Preoperative serum prostate-specific antigen and gleason grade as predictors of pathologic stage in clinically organ confined prostate cancer: Implications for the choice of primary treatmentInternational Journal of Radiation Oncology*Biology*Physics, 1994
- RESULTS OF EXTERNAL BEAM RADIOTHERAPY IN 448 PATIENTS WITH CLINICALLY LOCALIZED ADENOCARCINOMA OF THE PROSTATEAnz Journal of Surgery, 1994
- Surgically staged patients with prostatic carcinoma treated with definitive radiotherapy: fifteen-year resultsUrology, 1994
- Localized carcinoma of the prostate (Stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapyCancer, 1993
- Prostate Specific Antigen in the Management of Patients with Localized Adenocarcinoma of the Prostate Treated with Primary Radiation TherapyJournal of Urology, 1991
- The outcome of treatment of 313 patients with T-1 (UICC) prostate cancer treated with external beam irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Definitive radiotherapy in resectable (stage A2 and B) carcinoma of the prostate—Results of a nationwide overviewInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958